Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States

INTRODUCTION: The treatment of multiple myeloma (MM) remains a challenge as patients eventually progress through several lines of therapy (LOTs), requiring use of multiple MM drug classes. In this retrospective US claims-database study, we examined the healthcare costs of patients with MM who receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagannath, Sundar, Joseph, Nedra, He, Jinghua, Crivera, Concetta, Fu, Alex Z., Garrett, Ashraf, Shah, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681939/
https://www.ncbi.nlm.nih.gov/pubmed/35579821
http://dx.doi.org/10.1007/s40487-022-00198-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681939/
https://www.ncbi.nlm.nih.gov/pubmed/35579821
http://dx.doi.org/10.1007/s40487-022-00198-0

Ejemplares similares